Related Experiment Video
Updated: Apr 20, 2026
08:45
Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
Published on: July 17, 2020
6.8K
Are we using the right pharmacological tools to target EphA4?
Massimiliano Tognolini1, Matteo Incerti, Alessio Lodola
1Dipartimento di Farmacia, Università di Parma , Viale delle Scienze 27/a, 43124 Parma, Italia.
ACS Chemical Neuroscience
|November 19, 2014
Summary
Developing new drugs targeting the EphA4 receptor is crucial for treating neurodegenerative diseases. Current small molecules are insufficient, necessitating novel pharmacological tools for further research.
Area of Science:
- Neuroscience
- Pharmacology
- Drug Discovery
Background:
- The EphA4 receptor is implicated in neurodegenerative diseases.
- Blocking EphA4 activity is a potential therapeutic strategy.
Purpose of the Study:
- To highlight the need for improved small molecules targeting the EphA4 receptor's extracellular domain.
- To emphasize the inadequacy of current compounds for preclinical research.
Main Methods:
- Review of existing research on EphA4 inhibitors.
- Analysis of chemical and pharmacological profiles of identified compounds.
Main Results:
- No current small molecules effectively block EphA4 for animal model studies.
- Existing compounds lack suitable chemical and pharmacological properties.
Conclusions:
- Further development of pharmacological tools is essential.
- New efforts are required to create a new generation of EphA4-targeting drugs.
More Related Videos
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
108
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
108
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
74
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
74
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
588
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
588
01:27Transducer Mechanism: Enzyme-Linked Receptors
5.1K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
5.1K
01:22Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.8K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.8K
01:26Targets for Drug Action: Overview
12.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
12.0K